Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery

Obesity

Volumn 16, Issue 8, 2008, Pages 1831-1837

  Mingrone, Geltrude ^a   Manco, Melania ^b   Iaconelli, Amerigo ^a   Gniuli, Donatella ^a   Bracaglia, Roberto ^a   Leccesi, Laura ^a   Calvani, Menotti ^a   Nolfe, Giuseppe ^c   Basu, Subhabrata ^d   Berria, Rachele ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c CNR   (Italy)

^d METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; INSULIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PROLACTIN; SEX HORMONE BINDING GLOBULIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BIOPSY; BLOOD; CIRCADIAN RHYTHM; ENERGY METABOLISM; ENZYMOLOGY; FEMALE; FOLLOW UP; FOURIER ANALYSIS; GENETICS; HUMAN; INSULIN RESISTANCE; METABOLISM; MORBID OBESITY; PATHOLOGY; PHYSIOLOGY; SECRETION;

ADIPOSE TISSUE; ADULT; BARIATRIC SURGERY; BIOPSY; CIRCADIAN RHYTHM; ENERGY METABOLISM; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; FOURIER ANALYSIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; OBESITY, MORBID; PROLACTIN; RNA, MESSENGER; SEX HORMONE-BINDING GLOBULIN;

EID: 48749111852     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.297     Document Type: Article

References (36)

1. Greenman Y, Tordjman K, Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 1998;48:547-553.
2. Schmid C, Goede DL, Hauser RS, Brandle M. Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss Med Wkly 2006;136:254-258.
3. Delgrange E, Donckier J, Maiter D. Hyperprolactinaemia as a reversible cause of weight gain in male patients? Clin Endocrinol (Oxf) 1999;50:271.
4. Baptista T, Lacruz A, Meza T et al. Antipsychotic drugs and obesity: is prolactin involved? Can J Psychiatry 2001;46:829-834.
5. Marder SR, Essock SM, Miller AL et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004;161:1334-1349.
6. Doknic M, Pekic S, Zarkovic M et al. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 2002;147:77-84.
7. Moore BJ, Gerardo-Gettens T, Horwitz BA, Stern JS. Hyperprolactinemia stimulates food intake in the female rat. Brain Res Bull 1986;17:563-569.
8. Ling C, Hellgren G, Gebre-Medhin M et al. Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice. Endocrinology 2000;141:3564-3572.
9. Matsuda M, Mori T, Sassa S et al. Chronic effect of hyperprolactinemia on blood glucose and lipid levels in mice. Life Sci 1996;58:1171-1177.
10. Ling C, Svensson L, Oden B et al. Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. J Clin Endocrinol Metab 2003;88:1804-1808.
11. Flint DJ, Binart N, Kopchick J, Kelly P. Effects of growth hormone and prolactin on adipose tissue development and function. Pituitary 2003;6:97-102.
12. Flint DJ, Vernon RG. Effects of food restriction on the responses of the mammary gland and adipose tissue to prolactin and growth hormone in the lactating rat. J Endocrinol 1998;156:299-305.
13. Sassin JF, Frantz AG, Weitzman ED, Kapen S. Human prolactin: 24-hour pattern with increased release during sleep. Science 1972;177:1205-1207.
14. Veldhuis JD, Johnson ML. Operating characteristics of the hypothalamo-pituitary-gonadal axis in men:circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 1988;67:116-123.
15. Van Cauter E, L'Hermite M, Copinschi G et al. Quantitative analysis of spontaneous variations of plasma prolactin in normal man. Am J Physiol 1981;241:E355-E363.
16. Copinschi G, De Laet MH, Brion JP et al. Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity. Clin Endocrinol (Oxf) 1978;9:15-26.
17. Kok P, Roelfsema F, Langendonk JG et al. Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women. Am J Physiol Endocrinol Metab 2006;290:E218-E224.
18. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity. II. Initial experience in man. Br J Surg 1979;66:618-620.
19. Moore FD, Olesen KH, McMurrey JD et al. The Body Cell Mass and Its Supporting Environment: Body Composition in Health and Disease. Saunders: Philadelphia, PA, 1963.
20. Culebras JM, Fitzpatrick GF, Brennan MF, Boyden CM, Moore FD. Total body water and the exchangeable hydrogen. II. A review of comparative data from animals based on isotope dilution and desiccation, with a report of new data from the rat. Am J Physiol 1977;232:R60-R65.
21. Bonora E, Del Prato S, Bonadonna RC et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 1992;41:1151-1159.
22. Heymsfield SB, Lichtman S, Baumgartner RN et al. Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure. Am J Clin Nutr 1990;52:52-58.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
24. Granato L, Brandes A, Bruni C, Greco AV, Mingrone G. VO2, VCO2, and RQ in a respiratory chamber: accurate estimation based on a new mathematical model using the Kalman-Bucy method. J Appl Physiol 2004;96:1045-1054.
25. Auboeuf D, Vidal H The use of the reverse transcriptase-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Ann Biochem 1997;245:141-148.
26. Berria R, Wang L, Richardson DK et al. Increased collagen content in insulin-resistant skeletal muscle. Am J Physiol Endocrinol Metab 2006;290:E560-E565.
27. Korner T. Fourier Analysis. Cambridge University Press: New York, 1988.
28. Munson PJ, Roadbard D. Pulse detection in hormone data: simplified, efficient algorithm. In: Proceedings of the Statistical Computing Section of the American Statistical Association, Washington, DC, 1989, pp 295-300 〈www.http://abs.cit.nih.gov/pulsefit/pulshtml.html〉
29. Kok P, Roelfsema F, Frölich M et al. Activation of dopamine D2 receptors lowers circadian leptin concentrations in obese women. J Clin Endocrinol Metab 2006;91:3236-3240.
30. Mingrone G, Manco M, Granato L et al. Leptin pulsatility in formerly obese women. FASEB J 2005;19:1380-1382.
31. Ravussin E. Energy metabolism in obesity. Studies in the Pima Indians. Diabetes Care 1993;16:232-238.
32. Hainer V, Stich V, Kunesova M et al. Effect of 4-wk treatment of obesity by very-low-calorie diet on anthropometric, metabolic, and hormonal indexes. Am J Clin Nutr 1992;56:281S-282S.
33. Lamberts SW, Visser TJ, Wilson JH. The influence of caloric restriction serum prolactin. Int J Obes 1979;3:75-81.
34. Spooner PM, Chernick SS, Garrison MM, Scow RO. Insulin regulation of lipoprotein lipase activity and release in 3T3-L1 adipocytes. Separation and dependence of hormonal effects on hexose metabolism and synthesis of RNA and protein. J Biol Chem 1979;254:10021-10029.
35. Otarod JK, Goldberg IJ. Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Curr Atheroscler Rep 2004;6:335-342.
36. Wise LS, Green H. Studies of lipoprotein lipase during the adipose conversion of 3T3 cells. Cell 1978;13:233-242.